Browsing by Author "Ghitza, Udi E"
Now showing items 1-8 of 8
-
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
Wu, Li-Tzy; John, William S; Ghitza, Udi E; Wahle, Aimee; Matthews, Abigail G; Lewis, Mitra; Hart, Brett; ... (12 authors) (Addiction (Abingdon, England), 2021-01-11)<h4>Background and aims</h4>Physician and pharmacist collaboration may help address the shortage of buprenorphine-waivered physicians and improve care for patients with opioid use disorder (OUD). This study investigated ... -
Bupropion and Naltrexone in Methamphetamine Use Disorder.
Trivedi, Madhukar H; Walker, Robrina; Ling, Walter; Dela Cruz, Adriane; Sharma, Gaurav; Carmody, Thomas; Ghitza, Udi E; ... (20 authors) (The New England journal of medicine, 2021-01)<h4>Background</h4>The use of naltrexone plus bupropion to treat methamphetamine use disorder has not been well studied.<h4>Methods</h4>We conducted this multisite, double-blind, two-stage, placebo-controlled trial with ... -
Integrating substance abuse care with community diabetes care: implications for research and clinical practice
Ghitza, Udi E; Wu, Li-Tzy; Tai, Betty -
Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data.
Wu, Li-Tzy; Zhu, He; Ghitza, Udi E (Drug and alcohol dependence, 2018-11)BACKGROUND:Chronic diseases are prevalent and the leading causes of mortality. Comorbidity of substance use disorders (SUDs) and chronic diseases is understudied to inform behavioral healthcare integration. OBJECTIVES:This ... -
Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.
Wu, Li-Tzy; Ghitza, Udi E; Batch, Bryan C; Pencina, Michael J; Rojas, Leoncio Flavio; Goldstein, Benjamin A; Schibler, Tony; ... (10 authors) (Drug and alcohol dependence, 2015-11)BACKGROUND:Comorbid diabetes and substance use diagnoses (SUD) represent a hazardous combination, both in terms of healthcare cost and morbidity. To date, there is limited information about the association of SUD and related ... -
Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes.
Wu, Li-Tzy; Ghitza, Udi E; Zhu, He; Spratt, Susan; Swartz, Marvin; Mannelli, Paolo (Drug and alcohol dependence, 2018-05)The majority of the U.S. healthcare resources are utilized by a small population characterized as high-risk, high-need persons with complex care needs (e.g., adults with multiple chronic conditions). Substance use disorders ... -
The opioid overdose epidemic: opportunities for pharmacists.
Wu, Li-Tzy; Ghitza, Udi E; Burns, Anne L; Mannelli, Paolo (Subst Abuse Rehabil, 2017) -
Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.
Wu, Li-Tzy; Brady, Kathleen T; Spratt, Susan E; Dunham, Ashley A; Heidenfelder, Brooke; Batch, Bryan C; Lindblad, Robert; ... (11 authors) (Contemp Clin Trials, 2016-01)BACKGROUND: The Affordable Care Act encourages healthcare systems to integrate behavioral and medical healthcare, as well as to employ electronic health records (EHRs) for health information exchange and quality improvement. ...